The Potential of Induced Pluripotent Stem Cells to Test Gene Therapy Approaches for Neuromuscular and Motor Neuron Disorders - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Frontiers in Cell and Developmental Biology Année : 2021

The Potential of Induced Pluripotent Stem Cells to Test Gene Therapy Approaches for Neuromuscular and Motor Neuron Disorders

Résumé

The reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) represents a major advance for the development of human disease models. The emerging of this technique fostered the concept of “disease in a dish,” which consists into the generation of patient-specific models in vitro . Currently, iPSCs are used to study pathological molecular mechanisms caused by genetic mutations and they are considered a reliable model for high-throughput drug screenings. Importantly, precision-medicine approaches to treat monogenic disorders exploit iPSCs potential for the selection and validation of lead candidates. For example, antisense oligonucleotides (ASOs) were tested with promising results in myoblasts or motor neurons differentiated from iPSCs of patients affected by either Duchenne muscular dystrophy or Amyotrophic lateral sclerosis. However, the use of iPSCs needs additional optimization to ensure translational success of the innovative strategies based on gene delivery through adeno associated viral vectors (AAV) for these diseases. Indeed, to establish an efficient transduction of iPSCs with AAV, several aspects should be optimized, including viral vector serotype, viral concentration and timing of transduction. This review will outline the use of iPSCs as a model for the development and testing of gene therapies for neuromuscular and motor neuron disorders. It will then discuss the advantages for the use of this versatile tool for gene therapy, along with the challenges associated with the viral vector transduction of iPSCs.
Fichier principal
Vignette du fichier
fcell-09-662837.pdf (548.25 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03217251 , version 1 (04-05-2021)

Identifiants

Citer

Marisa Cappella, Sahar Elouej, Maria Grazia Biferi. The Potential of Induced Pluripotent Stem Cells to Test Gene Therapy Approaches for Neuromuscular and Motor Neuron Disorders. Frontiers in Cell and Developmental Biology, 2021, 9, pp.62837. ⟨10.3389/fcell.2021.662837⟩. ⟨hal-03217251⟩
71 Consultations
48 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More